Covered recipient · General Payments record
ILDEFONSO I RODRIGUEZ RIVERA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$4,494.63
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,323.93 | 53 |
| Education | $74.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $140.76 | 1 |
| Janssen Biotech, Inc. | $135.97 | 6 |
| Lilly USA, LLC | $105.52 | 4 |
| E.R. Squibb & Sons, L.L.C. | $93.39 | 4 |
| Daiichi Sankyo Inc. | $80.18 | 4 |
| Inspire Medical Systems, Inc. | $76.98 | 2 |
| Astellas Pharma US Inc | $74.99 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $68.95 | 3 |
| Deciphera Pharmaceuticals Inc. | $65.59 | 2 |
| PFIZER INC. | $63.87 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $53.91 | 2 |
| ARRAY BIOPHARMA INC | $52.67 | 3 |
| Merck Sharp & Dohme Corporation | $50.48 | 3 |
| ABBVIE INC. | $46.83 | 2 |
| SpringWorks Therapeutics, Inc. | $43.78 | 2 |
| Sumitomo Pharma America, Inc. | $39.56 | 2 |
| SOBI, INC | $34.08 | 1 |
| Acerta Pharma LLC | $31.24 | 1 |
| TAIHO ONCOLOGY, INC. | $24.29 | 1 |
| Exelixis Inc. | $21.48 | 1 |
| TerSera Therapeutics LLC | $18.35 | 1 |
| Ipsen Biopharmaceuticals, Inc | $17.98 | 1 |
| Blueprint Medicines Corporation | $15.46 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.09 | 1 |
| GENZYME CORPORATION | $14.37 | 1 |
| MENARINI SILICON BIOSYSTEMS, INC. | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.